# Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM

> **NCT04428762** · NA · WITHDRAWN · sponsor: **Assaf-Harofeh Medical Center**

## Conditions studied

- T1DM

## Interventions

- **DEVICE:** I-Port Advance use

## Key facts

- **NCT ID:** NCT04428762
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** we decided to change the protocol completely to an RCT.
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04428762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04428762, "Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04428762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*